MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 05-16-2026
Cerner Corporation DPO Ratio 2011-2026 | CERN
Annual DPO Ratio Cerner Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 | 99.6 | 96.6 | 99.8 | 97.7 | 93.3 | 48.4 | - | 101 | 68 | 50.6 | 23.9 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 23.9 | 80.2 |
Quarterly DPO Ratio Cerner Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 129 | - | 117 | 107 | 102 | - | 102 | 120 | 102 | - | 101 | 105 | 105 | - | 107 | 94.4 | 84.6 | - | 104 | 95.3 | 102 | - | 115 | 100 | 96 | - | 99.7 | 96 | 52.9 | - | 104 | 77.2 | 95.7 | - | 121 | 116 | 104 | - | 78.9 | 73.4 | 57.5 | - | 57.5 | 65.2 | 62.8 | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 129 | 52.9 | 95.6 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Evolent Health
EVH
|
19.3 | $ 3.95 | 2.86 % | $ 451 M |  USA |
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | USA |
 |
Computer Programs and Systems
CPSI
|
38.7 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
HealthEquity
HQY
|
12.1 | $ 88.11 | 1.94 % | $ 7.59 B | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
GoodRx Holdings
GDRX
|
106 | $ 2.65 | 3.52 % | $ 944 M | USA |
 |
Akerna Corp.
KERN
|
5.62 | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
23.5 | $ 23.68 | -4.05 % | $ 2.95 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
86.9 | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
14 | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
28.6 | - | - | $ 2.33 B | USA |
 |
Health Catalyst
HCAT
|
23.8 | $ 1.29 | - | $ 90.2 M | USA |
 |
OptimizeRx Corporation
OPRX
|
19.3 | $ 4.94 | - | $ 91.7 M | USA |
 |
Schrödinger
SDGR
|
35.6 | $ 13.3 | 0.53 % | $ 977 M | USA |
 |
Phreesia
PHR
|
43.7 | $ 8.92 | 1.59 % | $ 533 M | USA |
 |
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
19.2 | $ 6.57 | - | $ 1.16 B | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
43.2 | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
10.4 | $ 7.96 | 0.63 % | $ 128 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
24.5 | $ 23.81 | 0.59 % | $ 715 M | USA |
 |
Omnicell
OMCL
|
25.7 | $ 44.41 | 1.49 % | $ 2.04 B | USA |
 |
Progyny
PGNY
|
166 | $ 24.88 | 0.77 % | $ 2.12 B | USA |
 |
So-Young International
SY
|
10.8 | $ 2.23 | -16.48 % | $ 174 M |  China |
 |
Veeva Systems
VEEV
|
15.9 | $ 160.17 | 1.2 % | $ 26.2 B | USA |
 |
Zhongchao
ZCMD
|
31 | $ 1.43 | -4.03 % | $ 4.89 M | China |